The Europe Dermatome Device Market should witness market growth of 5.1% CAGR during the forecast period (2023-2030).
The prospects of the market are significantly influenced by the expanding therapeutic application of dermatome devices in skin-rebuilding procedures for different patient groups. During the projected period, it is anticipated that dermatome device innovations that will aid in delivering better outcomes with an elevated level of precision and accuracy will achieve a solid market position. The demand for these devices is anticipated to expand as a result of factors including an increase in burn cases, a rise in cosmetic operations, and a high frequency of skin infections & pressure ulcers.
There has been an upsurge in the frequency of burn injuries requiring dermatome devices, which reconstruct the charred area with skin patches. These devices provide skin constitution for individuals with grade 3 burns and trauma. Additionally, it is employed in both adult and pediatric plastic operations.
The WHO estimates that between 10 and 12% of people in the Member States of the European Union have diabetes, which is an increase from previous estimates. This rise in prevalence goes hand in hand with the rising trends in bad diets, physical inactivity, socioeconomic deprivation, and obesity and overweight. These risk factors contribute not only to the development of diabetes but also to noncommunicable diseases (NCDs), such as cancer, cardiovascular disease, and chronic respiratory illness. This has prompted the governments of many Member States to introduce policies and initiatives aimed at raising the prevalence of diabetes. Germany, Portugal, and Cyprus have the highest percentages of diabetic people in this region. As a result, diabetic ulcers as well as other chronic wounds are becoming more common in these countries. Hence, the region presents lucrative growth prospects for the growth of the market.
The Germany market dominated the Europe Dermatome Device Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,587.9 Thousands by 2030. The UK market is estimated to grow at a CAGR of 4.2% during (2023-2030). Additionally, The France market would exhibit a CAGR of 5.9% during (2023-2030).
Based on Application, the market is segmented into Chronic Burn Care Treatments, General Surgery, Plastic Surgery and Reconstructive Surgery & Others. Based on Product, the market is segmented into Powered Dermatome Device (Pneumatic, Battery Operated, and Electric), Knife Dermatome Device and Drum Dermatome Device. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
The prospects of the market are significantly influenced by the expanding therapeutic application of dermatome devices in skin-rebuilding procedures for different patient groups. During the projected period, it is anticipated that dermatome device innovations that will aid in delivering better outcomes with an elevated level of precision and accuracy will achieve a solid market position. The demand for these devices is anticipated to expand as a result of factors including an increase in burn cases, a rise in cosmetic operations, and a high frequency of skin infections & pressure ulcers.
There has been an upsurge in the frequency of burn injuries requiring dermatome devices, which reconstruct the charred area with skin patches. These devices provide skin constitution for individuals with grade 3 burns and trauma. Additionally, it is employed in both adult and pediatric plastic operations.
The WHO estimates that between 10 and 12% of people in the Member States of the European Union have diabetes, which is an increase from previous estimates. This rise in prevalence goes hand in hand with the rising trends in bad diets, physical inactivity, socioeconomic deprivation, and obesity and overweight. These risk factors contribute not only to the development of diabetes but also to noncommunicable diseases (NCDs), such as cancer, cardiovascular disease, and chronic respiratory illness. This has prompted the governments of many Member States to introduce policies and initiatives aimed at raising the prevalence of diabetes. Germany, Portugal, and Cyprus have the highest percentages of diabetic people in this region. As a result, diabetic ulcers as well as other chronic wounds are becoming more common in these countries. Hence, the region presents lucrative growth prospects for the growth of the market.
The Germany market dominated the Europe Dermatome Device Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,587.9 Thousands by 2030. The UK market is estimated to grow at a CAGR of 4.2% during (2023-2030). Additionally, The France market would exhibit a CAGR of 5.9% during (2023-2030).
Based on Application, the market is segmented into Chronic Burn Care Treatments, General Surgery, Plastic Surgery and Reconstructive Surgery & Others. Based on Product, the market is segmented into Powered Dermatome Device (Pneumatic, Battery Operated, and Electric), Knife Dermatome Device and Drum Dermatome Device. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
Scope of the Study
By Application
- Chronic Burn Care Treatments
- General Surgery
- Plastic Surgery
- Reconstructive Surgery & Others
By Product
- Powered Dermatome Device
- Pneumatic
- Battery Operated
- Electric
- Knife Dermatome Device
- Drum Dermatome Device
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Zimmer Biomet Holdings, Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap, Inc. (B. Braun Melsungen AG)
- Surtex Instruments Ltd.
- Richard Wolf GmbH
- Shaanxi Xingmao Industry Co., Ltd.
- Aygun Surgical Instruments Co., Inc. (CEECAT Capital)
- Humeca BV (Holland Venture)
- Nouvag AG
- Novo Surgical Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Dermatome Device Market by Application
Chapter 4. Europe Dermatome Device Market by Product
Chapter 5. Europe Dermatome Device Market by End-use
Chapter 6. Europe Dermatome Device Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap, Inc. (B. Braun Melsungen AG)
- Surtex Instruments Ltd.
- Richard Wolf GmbH
- Shaanxi Xingmao Industry Co., Ltd.
- Aygun Surgical Instruments Co., Inc. (CEECAT Capital)
- Humeca BV (Holland Venture)
- Nouvag AG
- Novo Surgical Inc.
Methodology
LOADING...
